Femasys Inc. Reports Director/Officer Changes & Compensation
Ticker: FEMY · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, officer-appointment, director-election, compensation
Related Tickers: FYS
TL;DR
Femasys Inc. shaking up leadership and exec pay - big changes coming?
AI Summary
Femasys Inc. announced on October 13, 2025, a significant event concerning the departure of directors or certain officers, the election of directors, and the appointment of certain officers. The filing also covers compensatory arrangements for these officers. The company is incorporated in Delaware and headquartered in Suwanee, GA.
Why It Matters
Changes in key leadership and executive compensation can signal shifts in company strategy, governance, and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if unexpected, can introduce uncertainty about future strategy and execution.
Key Players & Entities
- Femasys Inc. (company) — Registrant
- October 13, 2025 (date) — Date of earliest event reported
- Suwanee, GA (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
FAQ
Who specifically departed from their roles at Femasys Inc. on or before October 13, 2025?
The filing indicates the departure of directors or certain officers, but does not name the specific individuals in the provided text.
Were there any new directors or officers elected or appointed on October 13, 2025?
Yes, the filing explicitly states the election of directors and the appointment of certain officers as events reported on October 13, 2025.
What are the details of the compensatory arrangements for the newly appointed or affected officers?
The filing notes that compensatory arrangements of certain officers are covered, but the specific details are not provided in this excerpt.
What is the principal executive office address for Femasys Inc.?
The principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, GA 30024.
What is the SIC code for Femasys Inc.?
The Standard Industrial Classification code for Femasys Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 606 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2025-10-17 17:15:42
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share FEMY Nasdaq Capital Marke
Filing Documents
- ef20057334_8k.htm (8-K) — 32KB
- ef20057334_ex10-1.htm (EX-10.1) — 50KB
- 0001140361-25-038516.txt ( ) — 225KB
- femy-20251013.xsd (EX-101.SCH) — 4KB
- femy-20251013_lab.xml (EX-101.LAB) — 22KB
- femy-20251013_pre.xml (EX-101.PRE) — 16KB
- ef20057334_8k_htm.xml (XML) — 4KB
02
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 13, 2025, Daniel Currie, Chief Operating Officer of Femasys Inc. (the "Company") informed the Company of his decision to retire from the Company, effective as of December 15, 2025. Mr. Currie will remain in his current role with the Company until his departure. Mr. Currie's decision to retire follows more than 20 years of dedicated service, having joined the Company in March 2004, and is based on personal health considerations, a desire to focus on family and the next chapter of his life. In connection with his planned retirement, on October 16, 2025, the Company and Daniel Currie entered into a Separation and General Release Agreement (the "Separation Agreement"). Under the terms of the Separation Agreement: Any outstanding equity awards will be treated as follows: unvested stock options will vest through the retirement date. Health benefits will continue under COBRA through December 31, 2026, with Company contributions consistent with current coverage levels. The Separation Agreement includes a general release of claims, as well as non-competition, non-solicitation, and confidentiality covenants customary for such agreements. The Company and Board of Directors extend their sincere appreciation to Mr. Currie for his more than 20 years of leadership and service and wish him the very best in his retirement.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Description 10.1 Separation Agreement 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: October 17, 2025